Table of Contents
Pan-D and Amoxicillin under CDSCO quality test: Batches of 48 drugs, including Paracetamol, Shelcal, Glimepiride, and Telmisartan, have failed the CDSCO quality standards for August 2024
Pan-D and Amoxicillin under CDSCO quality test:
The Central Drugs Standards Control Organisation (CDSCO) has flagged 48 drugs, including popular medications like Pan-D, Paracetamol, Shelcal, and Amoxicillin, as “Not of Standard Quality” (NSQ). This announcement has raised concerns about drug safety and quality control in the country
CDSCO Quality Test Flags 48 Drugs for Quality Issues
In its latest monthly report for August 2024, the CDSCO listed numerous drugs that failed to meet the required quality standards. These include widely used medications such as Pan-D and Amoxicillin, along with other popular treatments for common ailments like fever, vitamin deficiencies, diabetes, and high blood pressure. The failed batches of these drugs are being closely monitored for quality compliance.
What Are the Drugs Under the CDSCO Scanner?
The flagged drugs include:
Pan-D (antiacid)
Amoxicillin (antibiotic)
Paracetamol (IP 500 mg tablets)
Shelcal (Vitamin C and D3 tablets)
Glimepiride (anti-diabetic drug)
Telmisartan (for high blood pressure)
Vitamin B complex and C soft gels
These drugs are commonly used for conditions like acidity, bacterial infections, fever, high blood pressure, and diabetes. The inclusion of these high-selling medicines in the CDSCO quality test has led to increased scrutiny from healthcare professionals.
What is the “Not of Standard Quality (NSQ)” Alert?
The NSQ alert is a monthly notification issued by the CDSCO based on random sampling conducted at various labs by state drug officers. The drugs flagged under this alert often fail to meet certain quality parameters such as purity, potency, and shelf life. While most of these issues are considered minor and not life-threatening, the presence of widely used medications like Pan-D and Amoxicillin under CDSCO quality test has caused alarm.